CHANTEL HILLESTAD: Open Payments
NPI 1043508526 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,436 in 44 payments from 8 companies in 2025. Trend: 2023 $410 · 2024 $233 · 2025 $5,436
Consulting: $2,933Travel & lodging: $1,435Food & beverage: $1,004Education: $65
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 12 | $4,586 |
| ABBVIE INC. | 18 | $228 |
| Arcutis Biotherapeutics, Inc. | 1 | $190 |
| GENZYME CORPORATION | 2 | $159 |
| Janssen Biotech, Inc. | 4 | $127 |
| Amgen Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: SKYRIZI, Zoryve, DUPIXENT, TREMFYA, OTEZLA, Rhapsido, NEMLUVIO.
Industry payments across ND — which companies pay providers there.
